News
Review which funds and institutions currently hold Vanda Pharmaceuticals Inc (VNDA:XNAS) stock for ownership information.
Background: Subclinical hypothyroidism has been linked to adverse renal outcomes, but it is unknown whether treatment of subclinical hypothyroidism reduces the risk of these adverse outcomes. We ...
Ultrapotent synthetics, mostly from China, are easy to smuggle and mix into heroin, recreational drugs and gray-market ...
The United States market has experienced a positive trend, with a 1.5% increase over the last week and an impressive 18% rise over the past year, while earnings are anticipated to grow by 15% annually ...
Oil prices on Wednesday suffered a fourth straight session of losses, with U.S. president Donald Trump 's tariffs as the main reason, as the brash billionaire announced a new trade deal with Japan and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results